43602-417-10 |
43602-417 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
1000 TABLET in 1 BOTTLE (43602-417-10) |
43602-417-30 |
43602-417 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
30 TABLET in 1 BOTTLE (43602-417-30) |
43602-417-90 |
43602-417 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
90 TABLET in 1 BOTTLE (43602-417-90) |
43602-421-10 |
43602-421 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.1 mg/1 |
1000 TABLET in 1 BOTTLE (43602-421-10) |
43602-421-30 |
43602-421 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.1 mg/1 |
30 TABLET in 1 BOTTLE (43602-421-30) |
43602-421-90 |
43602-421 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.1 mg/1 |
90 TABLET in 1 BOTTLE (43602-421-90) |
43602-425-10 |
43602-425 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.15 mg/1 |
1000 TABLET in 1 BOTTLE (43602-425-10) |
43602-425-30 |
43602-425 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.15 mg/1 |
30 TABLET in 1 BOTTLE (43602-425-30) |
43602-425-90 |
43602-425 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.15 mg/1 |
90 TABLET in 1 BOTTLE (43602-425-90) |
31722-284-01 |
31722-284 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
100 TABLET in 1 BOTTLE (31722-284-01) |
31722-284-10 |
31722-284 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
1000 TABLET in 1 BOTTLE (31722-284-10) |
43602-420-10 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
1000 TABLET in 1 BOTTLE (43602-420-10) |
43602-420-30 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
30 TABLET in 1 BOTTLE (43602-420-30) |
43602-420-90 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
90 TABLET in 1 BOTTLE (43602-420-90) |
43602-424-10 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
1000 TABLET in 1 BOTTLE (43602-424-10) |
43602-424-30 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
30 TABLET in 1 BOTTLE (43602-424-30) |
43602-424-90 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
90 TABLET in 1 BOTTLE (43602-424-90) |
43602-428-10 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
1000 TABLET in 1 BOTTLE (43602-428-10) |
43602-428-30 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
30 TABLET in 1 BOTTLE (43602-428-30) |
43602-428-90 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
90 TABLET in 1 BOTTLE (43602-428-90) |